Value of the ajmaline-procainamide test to predict the effect of long-term oral amiodarone on the anterograde effective refractory period of the accessory pathway in the Wolff-Parkinson-White Syndrome
- 1 July 1983
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 52 (1) , 70-72
- https://doi.org/10.1016/0002-9149(83)90071-1
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Use of procainamide in patients with the Wolff-Parkinson-White syndrome to disclose a short refractory period of the accessory pathwayThe American Journal of Cardiology, 1982
- Disparity between the clinical and electrophysiologic effects of amiodarone in the treatment of recurrent ventricular tachyarrhythmiasAmerican Heart Journal, 1981
- AmiodaroneNew England Journal of Medicine, 1981
- Control of refractory life-threatening ventricular tachyarrhythmias by amiodaroneAmerican Heart Journal, 1981
- Amiodarone therapy in symptomatic, sustained refractory atrial and ventricular tachyarrhythmiasAmerican Heart Journal, 1981
- Effect of drugs in the wolff-parkinson-white syndromeThe American Journal of Cardiology, 1980
- Use of ajmaline in patients with the Wolff-Parkinson-White syndrome to disclose short refractory period of the accessory pathwayThe American Journal of Cardiology, 1980
- Effects of amiodarone studied by programmedelectrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardiaJournal of Electrocardiology, 1978
- Effect of amiodarone in the Wolff-Parkinson-White syndromeThe American Journal of Cardiology, 1976
- Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochlorideThe American Journal of Cardiology, 1974